Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Examination format at UFS to change
2011-04-22

A new examination format is to be followed from the coming examination in May 2011 at the University of the Free State (UFS). According to this, the additional examination opportunity is to follow on the heels of the main examination.

According to the new format, students who qualify to write examinations will be compelled to write their papers during the first opportunity, and will only be allowed to write an additional examination once their applications for this examination have been approved. Students who qualify for re-assessment and special examinations will automatically be admitted to the additional examination and will therefore be exempt from the application process.
 
According to Dr Saretha Brüssow, Head: Teaching and Learning at the UFS, the Examination Committee requested the investigation of the double examination which applied previously, due to the pressure it caused on the university systems.
 
She said that, besides this release of pressure on systems such as the registration process, the back-to-back semester-based examination system might also lead to a possible improvement of the academic success rate, due to the shorter time span between the first and the second examination opportunities.
 
Students attended classes poorly in the past due to the second examination opportunity, which took place during the following semester after classes had resumed. “In some cases it is specifically the student at risk, who cannot afford to miss classes, who makes use of the second examination opportunity.”
 
Dr. Brüssow said the registration process was also affected by the previous format due to students who wanted to receive their results first before they registered. Other delays which occurred as a result of the second examination opportunity, were the first annual graduation ceremony which took place late in the year, the awarding of bursaries, and the finalisation of residence accommodation. Adding on to this problematic nature is students who occupy residences in the following academic year without a formal application in order to write during the second examination opportunity in January.
 
The new format is applicable to all students, except those in the Faculty of Health. Main and South Campus students can direct enquiries to addexam@ufs.ac.za. Qwaqwa Campus students should email addexam@qwa.ufs.ac.za.  Information on the new examination format is also available on www.ufs.ac.za.
 
 
Media Release
21 April 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept